Ashikaga T, Borodic G, Sims E A
Diabetes. 1978 May;27(5):592-6. doi: 10.2337/diab.27.5.592.
Data based on the prospective study of Job et al. are reanalyzed while initial number of microaneurysms and duration of patient follow-up are controlled. The reported statistical difference in the rate of microaneurysm increase between the single- and the multiple-daily-injection groups may be due to a difference in a subgroup who had a larger number of microaneurysms initially and who were studied for a shorter period of time. No uniform difference was observed in the results of their treatment between the groups given a single injection and those given multiple injections. While this does not invalidate the conclusions of the study, it does point out the need for greater control in conducting future studies.
在控制微动脉瘤初始数量和患者随访时长的基础上,对乔布等人前瞻性研究的数据进行了重新分析。单剂量注射组和每日多次注射组之间微动脉瘤增加率的统计差异报告,可能是由于初始微动脉瘤数量较多且研究时间较短的亚组存在差异。单剂量注射组和多次注射组之间的治疗结果未观察到统一的差异。虽然这并不否定该研究的结论,但确实指出了在开展未来研究时需要更好地进行控制。